Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot

RegulatoryapprovedNegative

AI Analysis

Summary

Johnson & Johnson received FDA approval for a surgical robot, resulting in stock price declines for competitors Intuitive Surgical and Medtronic. The approval marks competitive movement in the surgical robotics market.

Outcome Details

FDA approval for J&J surgical robot

Importance:7/10

Sentiment:

-0.60

FDA_approvalsurgical_roboticscompetitive_threatmedical_devices

Related Companies

$JNJ

Read the original article

Published by Seeking Alpha Healthcare on July 22, 2026 4:23 PM

Read Original